Around mid June 15 (May to July 2020) as animal studies and Stage 1 & 2 COVID-19 vaccine trial results start to trickle in, talk begins to lower the expectation of the COVID-19 vaccines, from preventing infection or transmitting of the virus to protecting you from serious illness, hospitalisation or death – a different end point. [1] All initially fueled the only solution to provide is a “preventive shot as the route to return to pre-pandemic life.” This is curious since most people have no symptoms and need to get a PCR test to determine if they a “positive” for the virus!
Traditionally vaccines create neutralising immunity to stop the virus from infecting you, making you sick and your ability to transmit the pathogen. That is the reason health authorities call them “immunisation programs” as they are meant to provide “steriliing immunity”. Though influenza vaccines don’t meet that expectation so they begin comparing a COVID-19 vaccine to a flu shot.
“Experts say such a product [that only stops severe symptoms] would probably be widely used if approved, even if that’s as much as it contributes, until a more effective version comes to market.”…“Vaccines need to protect against disease, not necessarily infection, said Dennis Burton, an immunologist and vaccine researcher at Scripps Research in La Jolla, California.”
The public now needs to be re-trained as to what “protection” means!
A new gene technology product, categorised as “vaccines” began human trials in 2020, but as the data emerges the scientist realise it can’t deliver on the expectations of a traditional vaccine.